Sub-Agatston Coronary Calcification on Non-Contrast Cardiac CT and Cardiovascular Risk

Clicks: 1
ID: 315461
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #150 of 194 articles by views in european journal of preventive cardiology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 194 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Aims To develop assessments of low-density (“sub-Agatston”) coronary artery calcification (CAC) on non-contrast CT calcium score (CTCS) examinations to evaluate its association with the risk of atherosclerotic major adverse cardiac events (MACE) and with high-risk plaque (HRP) features from coronary CT angiography (CCTA). Methods We analyzed 1837 asymptomatic individuals from the CLARIFY CTCS registry (NCT04075162) and 1075 patients presenting at chest-pain clinics from the SCOT-HEART trial (NCT01149590). MACE comprised death, myocardial infarction, stroke, or revascularization. We developed the vulnerable calcium index (VCI), which quantifies the proportional CAC mass increase after region-growing from 130 HU (Agatston) to 110 HU. Cox models were adjusted for age, sex, diabetes, hypertension, smoking, baseline statin use, and Agatston score. The association between VCI and CCTA-defined HRP (low-attenuation plaque, positive remodeling, spotty calcifications, mixed plaque, punctate calcification, napkin-ring sign) was assessed in patients with paired CTCS and CCTA in SCOT-HEART. Results Median follow-up was 4.8 y (CLARIFY) and 4.9 y (SCOT-HEART). VCI was independently associated with MACE in both cohorts: CLARIFY (adjusted hazard ratio [HR] 1.12, 95% CI 1.02–1.22, p=0.02) per unit increase in VCI and SCOT-HEART (adjusted HR 1.16, 1.03–1.31, p=0.02). Patients in the top quartile of adjusted model risk had markedly higher event rates compared with the lowest quartile (CLARIFY HR 25.0; SCOT-HEART HR 33.7 vs Q1, p<0.005 for both). Addition of VCI to Agatston significantly improved C-index (CLARIFY: 0.62 to 0.66, p<0.001; SCOT-HEART: 0.72 to 0.75, p<0.001) and net reclassification index (CLARIFY: 0.52 [0.40, 0.64], p<0.005; SCOT-HEART: 0.72 [0.48, 0.94], p<0.005). In SCOT-HEART, VCI was associated with all HRP features (OR: 1.45 to 1.85, p<0.001), adjusted for Agatston score. Conclusion VCI captures sub-Agatston CAC linked to HRP and independently improves MACE prediction in both a primary-prevention and a mixed-risk symptomatic chest pain population. Incorporating VCI into CAC reporting may refine preventive risk stratification beyond the conventional Agatston score.
Reference Key
openalex_W7163027416 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Prerna Singh, Ammar Hoori, J C Lee, Michelle C Williams, Sadeer Al-Kindi, David E Newby, Sanjay Rajagopalan, David L Wilson
Journal european journal of preventive cardiology
Year 2026
DOI
10.1093/eurjpc/zwag285
URL
https://doi.org/10.1093/eurjpc/zwag285
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.